Tue, Dec 06, 2022 @ 23:04 GMT
HomeContributorsFundamental AnalysisCould Corrections On FI And FX Markets Run Further?

Could Corrections On FI And FX Markets Run Further?


The action occurred on FX markets yesterday with the single currency throwing off the shackles and rebounding against both the dollar and sterling. We must admit though that more than genuine euro strength, we were probably dealing with corrective action on both dollar and sterling strength. First signs of dollar fatigue came as very strong US eco data failed to reignite the reflation trade and with details of Biden’s infrastructure plan now in the open. EUR/USD broke through minor resistance at 1.1836 before closing near 1.1870. The next, and more important hurdle is EUR 1.1950 (38% retracement on this year’s slide). Taking out that level (and regaining the 1.20 handle) would improve the technical picture of the euro to “neutral”. On a trade-weighted basis, the greenback closed at 0.9233, the softest level since mid-March. Even USD/JPY finished lower yesterday, below 110. Sterling had a similar splendid run against the euro this year, thanks to the lead in the vaccination process and to the reversal of some lockdown measures. A buy-the-rumour, sell-the-fact effect could be at play at the start of the fresh quarter with promised moves going into effect. EUR/GBP fell prey to a mild short squeeze, sending the pair to a 0.8590 close, coming from an open near 0.89.

The slowdown of the reflation story showed on bond markets as well with US Treasuries eking out some additional gains and outperforming German Bunds. US yields declined by 1 bp (2-yr) to 5.2 bps (7-yr) with the belly of the curve significantly outperforming the wings. German yields added around 1 bp across the curve. Peripheral yield spreads vs Germany widened by 2 bps to 5 bps with Italy underperforming. European stock markets made a catch-up move with the US, gaining 0.5% to 1% while US indices trade more lacklustre, ending slightly down on the day. Eco data and events didn’t play any role of importance. US JOLTS job openings surged to the highest level since early 2019 in a sign that the labour market recovery still has quite some way to go. The IMF upgraded global forecasts for this year (6% from 5.5%) and next (4.4% from 4.2%), but that didn’t really come as a surprise.

Today’s eco calendar remains fairly thin with FOMC Minutes and speeches by several Fed-governors worth mentioning. Recent market moves eased pressure on the US central bank’s laissez-faire approach. While we remain longer term proponents of higher long term bond yields, we admit the current loss of momentum. From a technical point of view, corrections on FI and FX markets can easily run somewhat further, especially in current, thin, trading conditions.

News Headlines

Japanese PM Suga said he could call for snap elections before his term as head of the Liberal Democratic Party ends in September, Asahi newspaper reported. Suga took over the helmet from Shinzo Abe, who resigned last year citing health reasons. The last regular elections took place in 2017 and the next one isn’t due until October this year.

The Reserve Bank of India kept interest rates unchanged at a record-low 4% this morning. Facing headwinds from a second wave of the coronavirus, the RBI should remain accommodative, governor Das said, even though underlying CPI measures are testing the upper bound of the 2%-6% inflation target. The central bank also announced a 1tn rupee bond buying programme as well as extended a TLTRO liquidity scheme with 6 months. The Indian rupee slipped to USD/INR 73.8. An spike in bond yields in the run-up to the meeting is more than reversed.

The UK will start rolling out the Moderna vaccine for the first time to residents in west Wales from Wednesday. UK’s government ordered some 17m doses of the shot. The news comes after growing concerns around a possible link between the AstraZeneca vaccine and blood clots. Its manufacturer has paused its trial on children aged 6-17 as the British health agency MHRA is still investigating the matter of blood clotting in adult patients.

KBC Bank
KBC Bankhttps://www.kbc.be/dealingroom
This non-exhaustive information is based on short-term forecasts for expected developments on the financial markets. KBC Bank cannot guarantee that these forecasts will materialize and cannot be held liable in any way for direct or consequential loss arising from any use of this document or its content. The document is not intended as personalized investment advice and does not constitute a recommendation to buy, sell or hold investments described herein. Although information has been obtained from and is based upon sources KBC believes to be reliable, KBC does not guarantee the accuracy of this information, which may be incomplete or condensed. All opinions and estimates constitute a KBC judgment as of the data of the report and are subject to change without notice.

Featured Analysis

Learn Forex Trading